DeepMetrix LiveStats 6.2 User-Agent/Referer cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.3 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in DeepMetrix LiveStats 6.2. This issue affects some unknown processing. Executing a manipulation of the argument User-Agent/Referer can lead to cross site scripting. This vulnerability is registered as CVE-2002-0944. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability was found in DeepMetrix LiveStats 6.2. It has been declared as critical. This vulnerability affects an unknown functionality. The manipulation of the argument User-Agent/Referer with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
Cross-site scripting vulnerability in DeepMetrix LiveStats 5.03 through 6.2.1 allows remote attackers to execute arbitrary script as the LiveStats user via the (1) user-agent or (2) referrer, which are not filtered by the stats program.
The weakness was published 10/04/2002 (Website). The advisory is shared for download at archives.neohapsis.com. This vulnerability was named CVE-2002-0944. The exploitation appears to be easy. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (9390) and SecurityFocus (BID 5047†). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
06/18/2002 🔍10/04/2002 🔍
10/04/2002 🔍
07/29/2014 🔍
06/27/2024 🔍
Sources
Advisory: archives.neohapsis.comStatus: Not defined
Confirmation: 🔍
CVE: CVE-2002-0944 (🔍)
GCVE (CVE): GCVE-0-2002-0944
GCVE (VulDB): GCVE-100-18880
X-Force: 9390
SecurityFocus: 5047 - DeepMetrix LiveStats HTML Report Script Injection Vulnerability
Entry
Created: 07/29/2014 11:26Updated: 06/27/2024 08:04
Changes: 07/29/2014 11:26 (44), 06/09/2018 10:50 (6), 06/27/2024 08:04 (17)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.